France Biomarker Technologies Market
France Biomarker Technologies Market Research Report: By Product (Consumables, Instruments), By Profiling Technology (PCR, Imaging Technology, NGS), By Application (Cancer, Infectious Disease) andBy Research Area (Genomics, Proteomics)- Forecast to 2035
Industry Developments
The France Biomarker Technologies Market has seen notable developments and growth, particularly among key players such as Agilent Technologies, Merck Group, and Roche. Recently, in September 2023, Thermo Fisher Scientific announced the expansion of its analytical capabilities by introducing advanced biomarker discovery platforms tailored for cancer research, reflecting the increasing demand for precision medicine in France. Additionally, Abbott Laboratories' strategic partnership with local healthcare providers aims to enhance the accessibility of its biomarker tests, further advancing patient care solutions. In the sphere of mergers and acquisitions, Roche executed an acquisition of a French biotech firm specializing in molecular diagnostics in July 2023, enhancing its product portfolio in the biomarker sector. The market has also witnessed significant valuation increases, with reports indicating a rise in the demand for innovative biomarker technologies to support drug development processes. Notably, Illumina has contributed to the market's escalation by launching a new suite of genomic solutions in France in March 2022, driving the integration of biomarker technologies in diagnostics. The overall market dynamics in France reflect a robust investment environment and growing interest from various stakeholders in advancing biomarker research and applications.
Report Scope
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 1.3(USD Billion) |
| MARKET SIZE 2024 | 1.41(USD Billion) |
| MARKET SIZE 2035 | 3.89(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.665% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Agilent Technologies, Merck Group, Abbott Laboratories, Roche, Thermo Fisher Scientific, PerkinElmer, BristolMyers Squibb, Qiagen, Danaher Corporation, BioRad Laboratories, Genomics PLC, F. HoffmannLa Roche, Siemens Healthineers, Illumina |
| SEGMENTS COVERED | Product, Profiling Technology, Application, Research Area |
| KEY MARKET OPPORTUNITIES | Rising demand for personalized medicine, Advancements in genomics and proteomics, Increased R&D funding and collaborations, Growth in diagnostics and therapeutics, Expanding application in oncology and neurology |
| KEY MARKET DYNAMICS | Growing demand for personalized medicine, Advancements in precision diagnostics, Increasing healthcare expenditure, Rising prevalence of chronic diseases, Government funding for research initiatives |
| COUNTRIES COVERED | France |
FAQs
What is the expected market size of the France Biomarker Technologies Market in 2024?
The France Biomarker Technologies Market is expected to be valued at 1.41 billion USD in 2024.
What will the market size be in 2035?
By 2035, the market is projected to reach a valuation of 3.89 billion USD.
What is the expected CAGR for the France Biomarker Technologies Market between 2025 and 2035?
The expected CAGR for the market during this period is 9.665 percent.
Which segment of the market is expected to have higher growth from 2024 to 2035?
The consumables segment is expected to grow significantly, from 0.8 billion USD in 2024 to 2.19 billion USD in 2035.
What is the projected market value for instruments in the France Biomarker Technologies Market by 2035?
The instruments segment is anticipated to be valued at 1.7 billion USD in 2035.
Who are the key players in the France Biomarker Technologies Market?
Major players in the market include Agilent Technologies, Merck Group, Abbott Laboratories, and Roche.
What market trends are influencing growth in the France Biomarker Technologies Market?
Key trends include advancements in precision medicine and increases in R&D spending, driving market growth.
How does regionality affect the France Biomarker Technologies Market?
The market in France is influenced by its strong pharmaceutical industry and increasing investments in healthcare technology.
What challenges does the France Biomarker Technologies Market face?
Challenges include regulatory hurdles and high costs associated with biomarker development.
What applications are driving innovation in the France Biomarker Technologies Market?
Applications in drug development, diagnostics, and personalized medicine are key drivers of innovation in the market.
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”